Background {#Sec1}
==========

Clavicle fractures are common fractures with an incidence reported of 59.3 per 100,000 person years \[[@CR1]\]. Historically, these fractures were predominantly treated non-operatively. However, it has been reported that surgical treatment of displaced mid-shaft clavicle fractures (DMCF) leads to better union rates, improved early functional outcomes, and increased patient satisfaction \[[@CR2]--[@CR4]\]. The current gold standard in operative treatment is Open Reduction Internal Fixation (ORIF) using plates and screws. An alternative to this technique is internal fixation using intramedullary fixation devices. These devices aim to reduce the DMCF in a minimally invasive manner and thereby improving cosmetic satisfaction and union rates while lowering infection rates \[[@CR5]\]. There are multiple different intramedullary devices available. Some of these devices are made out of rigid stainless steel while others consist of flexible titanium alloys. Some are not fixated within the bone while others are fixated on either one or both sides of the midshaft clavicle fracture. Since these devices differ considerably in their specifications and characteristics the array and distribution of complications and functional outcomes may vary as well.

The aim of this systematic review is to generate an overview of functional outcomes and complications in the management of DMCF per available intramedullary devices.

Methods {#Sec2}
=======

Electronic databases (PubMed, ScienceDirect, Embase and Cochrane) and clinical trial registries ([ClinicalTrials.gov](http://clinicaltrials.gov), [controlled-trials.com](http://controlled-trials.com) (ISRCTN), Australian New Zealand Clinical Trials Registry (ANZCTR), Chinese Clinical Trial Registry (CCTR), EU Clinical Trials Register (EU-CTR) and The Netherlands National Trial Register (NTR)) were searched from their inception to February 2020. Keywords used to develop our search strategy were 'clavicle', 'fracture', 'intramedullary fixation'. The detailed search strategy is described in Additional file [1](#MOESM1){ref-type="media"}.

Inclusion criteria {#Sec3}
------------------

All titles and abstracts were screened and study inclusion was decided on by two reviewers (PH/TvD). In case of discrepancy in study inclusion, disagreements were discussed until consensus on eligibility was reached. If disagreement persisted after discussion, consensus was met consulting GH. References of retrieved eligible articles were searched for supplementary studies. Studies meeting the following criteria were included: Studies describing the functional outcomes, with use of any type of intramedullary fixation for DMCF.Studies describing complications, with use of any type of intramedullary fixation for DMCF.Only original studies were included.Studies written in English, Dutch, and German.Studies concerning skeletally mature patients.

Abstracts, theses, case reports, biomechanical studies, surgical technique papers, editorials, letters and conference proceedings were not included. Studies using Kirschner wires and screws were excluded. Studies concerning intramedullary fixation for open fractures, pathological fractures, multi-trauma patients, floating shoulders, non-unions or mal-unions were also excluded.

Data extraction {#Sec4}
---------------

Studies in the final study selection were divided into subgroups depending on type of implant and ranked according to their study design and level of evidence (Oxford Centre of Evidence Based Medicine) by 2 authors (PH, TvD). The level of evidence (LoE) rating is divided into 5 levels: level I indicates the highest evidence studies, level II high, level III moderate, level IV low and level V very low-evidence studies \[[@CR6]\]. Disagreement between the reviewers concerning quality assessment was resolved by discussion.

Data from all included studies were extracted with respect to specific characteristics including title, author, year of publication, number of clavicles reported, type of fracture, intramedullary device used, length of follow-up, functional outcomes, and type and number of complications. Date were extracted and checked for accuracy by PH and TvD. Discrepancies were resolved by discussion. This study was conducted and reported in accordance with the reporting guidance provided in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement \[[@CR7]\]. The protocol was prospectively registered in PROSPERO (CRD42018086518).

Risk of bias and quality assessment {#Sec5}
-----------------------------------

The Cochrane risk of bias tool was used for assessing risk of bias in randomized trials.

The risk of bias tool covers six domains of bias: selection bias, performance bias, detection bias, attrition bias, reporting bias, and other bias. Within each domain, assessments are made for one or more items, which may cover different aspects of the domain, or different outcomes \[[@CR8]\].

The ROBINS-I tool was used for assessing risk of bias in non-randomized studies of interventions \[[@CR9]\]. This tool assesses seven domains through which bias might be introduced. The first two domains, covering confounding and selection of participants into the study, address issues before the start of the interventions. The third domain addresses classification of the interventions themselves. The other four domains address issues after the start of interventions: biases due to deviations from intended interventions, missing data, measurement of outcomes, and selection of the reported result.

Publication bias was assessed only if 10 or more studies were included in the meta-analysis using funnel plots and Egger's (for continuous outcomes) and Peters' test (for proportions) for funnel plot asymmetry \[[@CR10]--[@CR12]\]. Sensitivity analyses were performed to assess the influence of study quality when there was more than 1 high quality study available according to the ROBINS-I.

The confidence in estimates were rated and described according to the recommendations of the GRADE working group as each outcome was assessed for potential risk of bias, inconsistency, imprecision, indirectness and publication bias \[[@CR13]\].

Data analysis {#Sec6}
-------------

A meta-analysis was performed whenever three or more studies per intramedullary device that reported on a functional outcome or type of complication could be included.

Despite anticipated heterogeneity, the individual study proportions were pooled. Pooled estimates with their corresponding 95% confidence intervals were calculated using logit transformation (complications) or using untransformed data (functional outcome scores) within a random effects model framework. A continuity correction of 0.5 was applied if a study had an event probability of either 0 or 1. This continuity correction is used both to calculate individual study results with confidence limits and to conduct the meta-analysis. Heterogeneity of combined study results was assessed by I^2^, and its connected Chi-square test for heterogeneity, and the corresponding 95% confidence intervals were calculated. Restricted maximum likelihood was used to estimate the heterogeneity variance. 95% Prediction intervals were calculated to present the expected range of true effects in similar studies \[[@CR14]\].

Statistical analyses were performed using R version 3.4.4 (R Foundation for Statistical Computing, Vienna, Austria) with package 'meta'.

Results {#Sec7}
=======

The search strategy retrieved 368 unique records. Subsequent selection procedure resulted in 75 eligible articles of which 67 studies could be included in this systematic review and 62 in the meta-analysis (Additional file [2](#MOESM2){ref-type="media"}). In total, 10 studies concerning the Rockwood (DePuy, Warsaw, IN, USA) and Hagie pin (Smith & Nephew, Memphis, TN, USA) were identified and included in the analysis (two level I, \[[@CR15], [@CR16]\] two level III \[[@CR17], [@CR18]\] and six level IV \[[@CR19]--[@CR24]\] studies). These devices were evaluated together since they are essentially the same; they both consist of the exact same stainless-steel pin, with a cancellous and machine thread end, and two nuts. The only difference between the two is that the Rockwood pin also has a trocar point on the machine thread end of the pin. Concerning the Titanium Elastic Nail (TEN) (Depuy Synthes, Warsaw, IN, USA or Stryker, Kalamazoo, MI, USA) the 43 studies that were incorporated in the analysis were comprised of seven level I, \[[@CR25]--[@CR31]\] eight level II, \[[@CR32]--[@CR39]\] eleven level III \[[@CR40]--[@CR50]\] and seventeen level IV \[[@CR5], [@CR51]--[@CR66]\] studies. Another type of fixation described was the Sonoma CRx (Arthrex, Naples, FL, USA) for which 6 studies (three level I, \[[@CR67]--[@CR69]\] one level II, \[[@CR70]\] one level III \[[@CR71]\] and one level IV \[[@CR72]\]) were identified. Less frequently described intramedullary fixation devices were the threaded titanium elastic nails (Kang Li Min Medical Devices Co. Ltd., Tianjin, China), \[[@CR73]--[@CR75]\] the Knowles pin (Zimmer Biomet, Warshaw, IN, USA) \[[@CR76]--[@CR79]\] and one study describing a second generation Titanium elastic nail (Puwei Medical Appliances Inc., Shanghai, China) \[[@CR80]\]. Table [1](#Tab1){ref-type="table"} displays study characteristics including population description, type of intramedullary device, functional outcome scores, and type and number of complications. Table 1Study characteristicsFunctional OutcomesComplicationsAuthorYearLevel of EvidenceStudy DesignNumber of PatientsClaviclesCMS(SD) at 12monthsDASH(SD) at 12monthsQuickDASH(SD) at 12monthsNumber of complicationsHardware irritationSoft tissue problemsHardware failureInfectionNon-unionProtrusion/Telescoping/MigrationDelayedunionMalunionPainCosmetic dissatisfaction**RockwoodPin&HagiePin** Strauss et al.20074RCS161683201 Judd et al.20091RCT29292191811 Ferran et al.20101RCT171792.1(6)4110 Mudd et al.20114RCS1818163323211 Kleweno et al.20113RCS1818521110 Millett et al.20114RCS51511552251 Payne et al.20114RCS68686230372115 Frye et al.20124RCS1717117120 Marlow et al.20124RCS70705.9^a^31124821 Wenninger et al.20133RCS33333210**TEN** Jubel et al.20022PCS656596.9(3.3)8215 Jubel et al.20023RCC202097(4)00 Jubel et al.20033RCS555897.9(3.3)932012 Jubel et al.20032PCS121298.3(1.5)000 Jubel et al.20052PCC2626208002 Kettler et al.20054RCS555581(7.1)3114201622 Walz et al.20062PCS353598.1(1.3)65001 Keener et al.20064RCS24241362113 Kettler et al.20074RCS878784(9)6.9(7.2)23402474 Mueller et al.20074RCS323295(1.9)5(2.3)1652108 Witzel20072RCT35350 Hartmann et al.20084RCS151595.3(3.9)4400 Frigg et al.20094RCS34341.5(3.2)24710151 Smekal et al.20091RCT303097.9(1.7)1020071 Liu et al.20103RCC515186.7(5.3)13.5(3.9)2044354 Frigg et al.20113RCC44441.4(3.1)145116 Chen et al.20111RCT303097(4.3)2.74(3.6)1031103 Assobhi20111RCT191995.5(5.3)430001 Smekal et al.20111RCT606098(3.6)0.5(1.8)19521072 Kadakia et al.20124RCS38386.7(3.4)1118001 Wijdicks et al.20124RCS47476029140262 Tarng et al.20123RCC252596(2)4400 Chen et al.20123RCC575795(3.2)4(4.4)32431117 Prokop et al.20134RCS13613697(3)11 Langenhan et al.20144RCS373796.0(5.3)3(5)4103 Saha et al.20142PCC343493.5(4.4)131200 Shokouh et al.20144RCS1213000 Braun et al.20144RCS404086.3(8.1)5.5(6.9)1912012 Narsaria et al.20142PCC333394.6(3.2)4111 Suresha et al.20144RCS202094.6^a^0000 Lu et al.20144RCS272793,6(9)6.2(11.1)1780009 Wang et al.20153RCC252593.8(8.9)5.5(10.5)1250005 Andrade-Silva et al.20151RCT252591.8(8.8)7.5(12.5)10101 vanderMeijden et al.20151RCT626296.3(11.8)3.9(10.2)4333 Eden et al.20152PCC2424511121 Mishra et al.20163PCC737396.8(2.3)1573023 Lechler et al20163RCC363687.7(10.7)3.9(6.6)123 Fuglesang et al.20171RCT60603619421 Govindasamy et al.20174RCS545497.8(1)19153011 Eickhoff et al.20183RCC999939291226 Eisenstein et al.20184RCS774211 Frima et al.20184RCC34342040 Zhang et al.20193RCC373797.3(13.7)2010**SonomaCRx** Zehir et al.20151RCT24247.7(2.2)810034 King et al.20152PCS474790(13)11(18)3210 Zehir et al.20154RCS171794.3(2.8)11.8(2.5)2110 Calbiyik et al.20161RCT353592.9(4)3.8(1.6)521011 ZehirS et al.20163RCC333394.3(5.3)412021 Kingetal.20191RCT353597(5)5(6)3110**ThreadedPin** Zenni et al.19814RCS21217100 Grassi et al20013RCC404082.9(8)15822 Bi et al.20152PCS454596.5(9)1.4(12.5)2019100**KnowlesPin** Chu et al20024RCS787892(13.8)413 Lee et al20072RCT323285(8.8)0 Lee et al.20083RCC565644 Wu et al.20134RCC3373371919**2**^**nd**^**GenerationTEN** Fu20164RCC363693.4(2.7)2.5(1.6)312*RCS* retrospective case series, *RCC* retrospective comparative cohort, *PCS* prospective case series, *PCC* prospective comparative cohort, *RCT* randomized clinical trail^a^No range or SD reported

Risk of bias assessment {#Sec8}
-----------------------

The results of the Cochrane risk of bias tool are summarized in Table [2](#Tab2){ref-type="table"} and shows high risk of bias in domains 3 and 4 assessing performing and detection bias. The results of the ROBINS-I risk of bias assessment, summarized in Table [3](#Tab3){ref-type="table"} shows that the overall ROBINS-I score for most studies were subject to serious or critical risk of bias. Table 2Cochrane risk of bias assessment of randomized trials*Green* low risk, *Red* high risk, *Yellow* Unknown RiskTable 3ROBINS-I assessing risk of bias in non-randomized studies of interventionsAuthorYearDomain 1: ConfoundingDomain 2:\
Selection of participantsDomain 3:\
Classification of interventionDomain 4:\
Deviation from interventionsDomain 5:\
Missing data DomainDomain 6:\
Measurement of outcomesDomain 7:\
Selection of reported resultsROBINS-I overall**Sonoma CRx** Zehir et al.201522212222 King et al.201533212223 Zehir et al.201533213223 Calbiyik et al.201621111222 Zehir S et al.201632212233**Rockwood Pin & Hagie Pin** Strauss et al.200743312334 Judd et al.200922111222 Ferran et al.201022211222 Mudd et al.201133211323 Kleweno et al.201132211333 Millett et al.201133312223 Payne et al.201132212223 Frye et al.201233312333 Marlow et al.201233212223 Wenninger et al.201332212323**TEN** Jubel et al.200222112222 Jubel et al.200223211223 Jubel et al.200333212233 Jubel et al.200333112223 Jubel et al.200523111223 Kettler et al.200543112224 Walz et al.200622111222 Keener et al.200643213233 Kettler et al.200733212223 Mueller et al.200722111212 Witzel200732212223 Hartmann et al.200833212233 Frigg et al.200932122233 Smekal et al.200922111222 Liu et al.201033212233 Frigg et al.201122113223 Chen et al.201122111222 Assobhi201122211222 Smekal et al.201122111222 Kadakia et al.201243212324 Wijdicks et al.201232312323 Tarng et al.201233312223 Chen et al.201233212223 Prokop et al.201333213233 Langenhan et al.201423212233 Saha et al.201432212223 Shokouh et al.201423212323 Braun et al.201423212223 Narsaria et al.201422112222 Suresha et al.201433212223 Lu et al.201423112223 Wang et al.201523112223 Andrade-Silva et al.201521111212 van der Meijden et al.201521111212 Eden et al.201532212223 Mishra et al.201622212222 Lechler et al201633212223 Fuglesang et al.201722112222 Govindasamy et al.201733213222 Eickhoff et al.201822112222 Eisenstein et al.201832212223 Frima et al.201822212222 Zhang et al.201923213333**Threaded Pin** Zenni et al.198144212324 Grassi et al200133212223 Bi et al.201522212222**Knowles Pin** Chu et al200233233233 Lee et al200732212223 Lee et al.200833212223 Wu et al.201332212323*1* low risk of bias, *2* moderate risk of bias, *3* serious risk of bias, *4* critical risk of bias

Studies concerning the Rockwood pin and Hagie pin {#Sec9}
-------------------------------------------------

All studies identified concerning these devices described an identical surgical technique. All pins were removed after union between 6 and 20 weeks through a secondary surgical intervention. Average follow-up of the studies ranged between 6 months and 7 years. The functional outcome scores reported were heterogeneous and therefore not comparable. Only two studies reported a Constant-Murley (92.1 ± 6) \[[@CR15]\] or DASH (5.9) \[[@CR19]\]. Other functional outcome scores reported were the Oxford Shoulder Score (45.2 ± 2.3), \[[@CR15]\] L'Insalata (95.5 ± 7.3), \[[@CR16]\] and ASES (88.6 and 89) \[[@CR20], [@CR24]\].

### Meta-analysis: {#Sec10}

It was not possible to perform a meta-analysis for functional outcomes. A meta-analysis was performed for 6 different complications. Data from 10 studies were used to evaluate nonunion followed by data from 7 studies for infection. Seven studies reported hardware irritation, soft tissue problems \[[@CR15], [@CR17], [@CR19]--[@CR21], [@CR23], [@CR24]\] and hardware failure \[[@CR15]--[@CR17], [@CR20], [@CR22]--[@CR24]\]. Four studies were included in a meta-analysis for persistent pain. (Fig. [1](#Fig1){ref-type="fig"}) The highest pooled incidences were found for complications hardware irritation (22, 95%CI 13--35 in 253 clavicles), soft tissue problems (9, 95%CI 6--13 in 207 clavicles) and infection (9, 95%CI 5--16 in 287 clavicles). A pooled incidence of unspecified persistent pain was reported in 6% (95%CI 2--20 in 172 clavicle) of cases. The pooled incidence of hardware failure and nonunion was 6% (95%CI 3--10 in 216 clavicles) and 3% (95%CI 1--8 in 337 clavicles) respectively. Fig. 1Forest plots of the included studies using the Rockwood and Hagie Pin reporting on (**a**) hardware irritation, (**b**) infection, (**c**) soft tissue problems, (**d**) persistent pain, (**e**) hardware failure, (**f**) nonunion, (**g**) scar numbness, and (**h**) delayed union. Forest plots display the mean proportion of complications (**a**-**f**), 95% confidence interval and the relative weight of the individual studies. The diamond indicates the pooled estimate and its 95% confidence interval. The red bar indicates the 95% prediction interval. Prediction intervals illustrate which range of true effects expected to occur in similar studies in future settings

The confidence in the estimates from the meta-analyses according to GRADE ranged between low and very low (Table [4](#Tab4){ref-type="table"} and Additional file [3](#MOESM3){ref-type="media"}). Table 4Summary of findings table including GRADEDeviceOutcomeNo. of StudiesNo. of ClaviclesEffect estimate (95%CI))Quality of evidence (GRADE)**Rockwood Pin & Hagie Pin**Hardware Irritation72530.22 (0.13--0.35)⨁⨁⨀⨀ LOWInfection72870.09 (0.05--0.16)⨁⨁⨀⨀ LOWSoft Tissue Problems72070.09 (0.06--0.13)⨁⨁⨀⨀ LOWPain41720.06 (0.02--0.20)⨁⨀⨀⨀ VERY LOWHardware Failure72160.06 (0.03--0.10)⨁⨁⨀⨀ LOWNonunion61910.00 (0.00--0.04)⨁⨁⨀⨀ LOWScar Numbness41730.05 (0.02--0.09)⨁⨀⨀⨀ VERY LOWDelayed Union41660.02 (0.01--0.06)⨁⨀⨀⨀ VERY LOW**TEN**CMS29127094.40 (93.43--95.37)⨁⨁⨁⨁ HIGHDASH156474.65 (2.61--6.68)⨁⨁⨁⨁ HIGHHardware Irritation3012730.20 (0.14--0.26)⨁⨁⨁⨀ MODERATEProtrusion2511050.12 (0.08--0.18)⨁⨁⨁⨀ MODERATEMalunion31930.07 (0.04--0.11)⨁⨁⨀⨀ LOWSoft Tissue Problems84060.04 (0.03--0.08)⨁⨀⨀⨀ VERY LOWPain31360.04 (0.02--0.09)⨁⨀⨀⨀ VERY LOWNonunion3614360.03 (0.02--0.04)⨁⨁⨁⨀ MODERATEHardware Failure198000.03 (0.02--0.05)⨁⨁⨀⨀ LOWDelayed Union62650.03 (0.02--0.06)⨁⨀⨀⨀ VERY LOWInfection2910840.02 (0.01--0.03)⨁⨁⨁⨀ MODERATE**Sonoma CRx**CMS516794.03 (92.31--95.76)⨁⨁⨁⨀ MODERATEDASH3999.16 (3.94--14.37)⨁⨁⨁⨀ MODERATECosmetic Dissatisfaction3920.06 (0.02--0.17)⨁⨀⨀⨀ VERY LOWHardware Failure61910.04 (0.02--0.08)⨁⨁⨀⨀ LOWInfection61910.03 (0.01--0.07)⨁⨁⨀⨀ LOWNonunion61910.00 (0.00--0.04)⨁⨁⨀⨀ LOW**Threaded Pin**Infection31060.01 (0.00--0.64)⨁⨀⨀⨀ Very Low**GRADE Working Group grades of evidenceHigh certainty:** We are very confident that the true effect lies close to that of the estimate of the effect**Moderate certainty:** We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different**Low certainty:** Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect**Very low certainty:** We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

Studies concerning the titanium elastic nail (TEN) {#Sec11}
--------------------------------------------------

The first reports on using TEN in the treatment of DMCF dated from 2002 \[[@CR35]\]. TENs with a diameter varying between 2 and 3.5 mm were used. Closed reduction rates were reported in 28 of 35 studies. The rates ranged from 15% \[[@CR46]\] to 93% \[[@CR27]\]. Most studies report a routine removal of the TEN in all cases mostly through a second surgical intervention but also removal under local anesthesia was described. The earliest routine nail removal was performed at 3 months \[[@CR56]\] and the latest on average at 8.8 months \[[@CR25]\].

### Meta-analysis: {#Sec12}

A meta-analysis was performed for functional outcomes based on 30 studies reporting the Constant-Murley Score and 15 studies reporting a DASH score. (Fig. [2](#Fig2){ref-type="fig"}) The pooled data for the Constant-Murley score and DASH score at 12 months is 94.4 (95%CI 93.4--95.4 in 1290 clavicles) and 4.6 (95%CI 2.6--6.7 in 647 clavicles), respectively (Fig. [2](#Fig2){ref-type="fig"}). The confidence in the estimates from the meta-analyses according to GRADE concerning the functional outcomes were considered high due to the consistency and precision of the data in combination with the large number of clavicles involved (Table [4](#Tab4){ref-type="table"} and Additional file [3](#MOESM3){ref-type="media"}). The functional outcomes of two studies were not included in the meta-analysis \[[@CR28], [@CR31]\]. Fuglesang et al. \[[@CR28]\] report the Constant-Murley and DASH scores of 60 TENs only by means of a line graph and van der Meijden et al. \[[@CR31]\] report in-text Constant-Murley scores at 1 year follow up that differ from the line graph displayed. Visual evaluation of the line graphs however seems similar to the pooled incidences from the meta-analysis. Fig. 2Forest plots of the included studies using the Titanium Elastic Nail reporting on (**a**) Constant-Murley score at 12 months, and (**b**) DASH score at 12 months. 95% confidence interval and the relative weight of the individual studies. The diamond indicates the pooled estimate and its 95% confidence interval. The red bar indicates the 95% prediction interval. Prediction intervals illustrate which range of true effects expected to occur in similar studies in future settings

Data from 43 studies were pooled in the meta-analysis for evaluating complications rates using the TEN. Twenty-nine studies reported on infection, 29 studies on hardware irritation, 25 studies on protrusion/telescoping/migration, 19 on hardware failure, 12 on nonunion, 8 on soft tissue problems, 5 on malunion and 3 on pain. (Fig. [3](#Fig3){ref-type="fig"}) The two most common complications reported, protrusion/telescoping/migration and hardware irritation, are implant-related. The pooled incidence was 12% (95%CI 8--18 in 1105 clavicles) and 20% (95%CI 14--26 in 1273 clavicles), respectively. Fig. 3Forest plots of the included studies using the Titanium Elastic Nail reporting on (**a**) hardware irritation, (**b**) protrusion/telescoping/migration, (**c**) malunion, (**d**) soft tissue problems, (**e**) pain, (**f**) nonunion, (**g**) hardware failure, (**h**) delayed union, and (**i**) infection. Forest plots display the mean proportion of complications (A-H), 95% confidence interval and the relative weight of the individual studies. The diamond indicates the pooled estimate and its 95% confidence interval. The red bar indicates the 95% prediction interval. Prediction intervals illustrate which range of true effects expected to occur in similar studies in future settings

Malunion after surgical management by means of a TEN was reported in 7% (95%CI 4--11 in 193 clavicles) and hardware failure was 3% (95%CI 2--5 in 800 clavicles). Pooled infection incidence was 2% (95%CI 0--3 in 1084 clavicles) and the pooled incidence of a nonunion using a TEN was 3% (95%CI 2--4 in 1436 clavicles). The confidence in the estimates from the meta-analyses according to GRADE concerning the functional outcomes ranged from moderate to very low (Table [4](#Tab4){ref-type="table"} and Additional file [3](#MOESM3){ref-type="media"}).

Studies concerning the Sonoma CRx {#Sec13}
---------------------------------

### Meta-analysis {#Sec14}

Six studies were included in the meta-analysis. Data from 5 studies were pooled for functional outcomes using the Constant-Murley score. The pooled Constant-Murley score at 12 months was 94.0 (95%CI 92--96 in 167 clavicles). Six studies reported on nonunion, infection and hardware failure. Three studies reported cosmetic dissatisfaction. (Fig. [4](#Fig4){ref-type="fig"}) The pooled incidence for cosmetic dissatisfaction was highest at 6% (95%CI 2--17 in 92 clavicles), followed by of hardware failure (4%; 95%CI 2--8 in 191 clavicles) and infection (3%; 95%CI 1--7 in 191 clavicles). No reports of non-union using the Sonoma CRx were reported, the pooled incidence was 0% (95%CI 0--4 in 191 clavicles). Fig. 4Forest plots of the included studies using the Sonoma CRx reporting on (**a**) Constant-Murley score at 12 months, (**b**) Disabilities of Arm, Shoulder and Hand Score at 12 months, (**c**) cosmetic dissatisfaction, (**d**) hardware failure, (**e**) infection, and (**f**) nonunion. Forest plots display the mean functional outcome (**a** and **b**) or proportion of complications (**c**-**f**), 95% confidence interval and the relative weight of the individual studies. The diamond indicates the pooled estimate and its 95% confidence interval. The red bar indicates the 95% prediction interval. Prediction intervals illustrate which range of true effects expected to occur in similar studies in future settings

Two studies reported on persistent pain as a complication \[[@CR68], [@CR71]\] and 1 study mentions the occurrence of a delayed union \[[@CR67]\].

The confidence in the estimates from the meta-analyses according to GRADE concerning the functional outcomes were considered moderate. Although the results were consistent, the data originate from very limited group of authors. The confidence in the other meta-analyses according to GRADE were low to very low (Table [4](#Tab4){ref-type="table"} and Additional file [3](#MOESM3){ref-type="media"}).

Studies concerning a threaded elastic nail {#Sec15}
------------------------------------------

Meta-analysis was only possible for infection \[[@CR73]--[@CR75]\] and the pooled incidence was 5% (95%CI 1--34 in 106 clavicles).

The confidence in the estimates from this meta-analysis according to GRADE was very low (Table [4](#Tab4){ref-type="table"} and Additional file [3](#MOESM3){ref-type="media"}: Additional file [3](#MOESM3){ref-type="media"}). Other complications described for this type of fixation were soft tissue problems, delayed union and malunion. (Table [2](#Tab2){ref-type="table"}).

Studies concerning the Knowles pin {#Sec16}
----------------------------------

One study reported 4 hardware irritations in 56 patients \[[@CR77]\] and another study reported a nonunion rate of 5.6% \[[@CR79]\]. No meta-analysis was possible for this device type.

Study concerning a second generation TEN {#Sec17}
----------------------------------------

One level IV study described the results of a second generation TEN in 36 patients \[[@CR80]\]. It reported a Constant-Murley score of 93.4 (SD2.7) and 3 complications; 2 protrusions and 1 hardware irritation.

Sensitivity analysis {#Sec18}
--------------------

The sensitivity analysis including only studies with a low risk of bias showed our results to be robust. The complete results of the sensitivity analysis can be found in Additional file [4](#MOESM4){ref-type="media"}.

Publication bias {#Sec19}
----------------

In those cases that publication bias could be assessed, its presence was unlikely based on the inspection of the funnel plots and evaluation of Egger's or Peters' tests. Only for the Constant Murley and DASH scores the tests for funnel plot asymmetry were significant, but publication bias seems unlikely here due to ceiling effects in both scores.

Discussion {#Sec20}
==========

In this study the functional outcomes and complications after surgical treatment of DMCF with an intramedullary device were systematically reviewed. Good functional results and union rates irrespective of the type of device are found in the reviewed literature. However, there are clear device-related and device-specific complications for each. The pooled Constant-Murley scores of the TEN and Sonoma CRx were 94.4 (95%CI 93--95) and 94.0 (95%CI 92--96), respectively. Since the Constant-Murley score ranges from 0 to 100 points and higher scores are better, the pooled scores can be considered good. Though the minimally clinical important difference (MCID) for both the Constant-Murley score is unknown for midshaft clavicular fractures in particular it is described that the MCID in Constant Murley scores for shoulder pathology is 10.4 points \[[@CR81]\]. Therefore, with an SD reported well within that range our conclusion seems valid as is the confidence in the estimate according to GRADE. The pooled DASH score for the TEN was 4.6 (95%CI 2.6--6.7). The functional outcomes for the Rockwood/Hagie pin could not be analyzed because all identified papers reported different functional outcome measures. This study supports the need for uniform reporting of functional outcomes and in the case of clavicle fracture treatment the Constant-Murley and the DASH are the ones most commonly used.

The most commonly reported complications after intramedullary fixation of DMCFs are implant-related and implant-specific complications. For the TEN, hardware irritation, protrusion, telescoping and migration, are major contributors to the total complication rate. The explanation for this finding may be that the TEN re-aligns but does not fixate in both fracture elements of the DMCF. These TEN-specific complications lead to infection, soft-tissue problems, pain, early re-interventions (removal or additional cutting of the nail) and loss of reduction with subsequent secondary shortening. When using the Rockwood/Hagie Pin, pooled incidence of hardware irritation was 22% (95%CI 13--35). This may be explained by the two bulky nuts at the posterolateral aspect of the clavicle where the pin is inserted and is has been reported to be an important disadvantage of the implant \[[@CR15], [@CR19], [@CR22]\]. For the Sonoma CRx no reports on hardware irritation were found since this device has no extra-cortical prominences and is fully embedded in the clavicular cortex.

With regards to the TEN, there is a pooled malunion incidence of 7% (95%CI 4--11). Reports on persistent average shortening after union range between 3.5 and 6.3 mm \[[@CR27], [@CR37], [@CR54]\]. Others report on shortening after union of more \> 1 cm in 2.3--50% of cases \[[@CR41], [@CR57], [@CR60]\]. Since shortening of the DMCF can lead to post-traumatic symptoms, altered scapular kinematics and the occurrence of gleno-humeral joint arthritis, shortening is an important issue to prevent and could be interpreted as a disadvantage of this intramedullary fixation device.

There are no studies specifically reporting on the presence or absence of post-operative shortening after fracture fixation with the Sonoma CRx. Concerning the Rockwood pin only Mudd et al. \[[@CR21]\] reports a secondary shortening of 4-7 mm in 22% of patients which all occurred after early pin removal due to complications.

The pooled incidence for infection was 9% (95%CI 5--16) when using the Rockwood/Hagie pin, 3% (95%CI 1--7) when using the Sonoma CRx and 2% (95%CI 0--3) with use of the TEN. The two postero-lateral nuts that can cause wound-breakdown and subsequent infection may explain the high infection rate of the Rockwood/Hagie pin.

Hardware failure was 6% (95%CI 3--10) for the Rockwood/Hagie Pin compared to 3% (95%CI 2--5) for TEN and 4% (95%CI 2--8).

Meta-analysis shows nonunion incidences to be similar between the Rockwood/Hagie pin (3%;95%CI 1--8) and to 3% (95%CI 2--4) with the use of the TEN. The pooled incidence of nonunion for the Sonoma CRx was 0% (95%CI 0--4). Although no non-unions were reported in the Sonoma CRx group the confidence this outcome according to GRADE was low due to the limited number of clavicles included and the select group of authors introducing the risk of bias.

This systematic review furthermore identified the common denominator amongst many authors that routine removal of hardware is not considered a complication. However, a case could be made that every secondary intervention including hardware removal is an additional procedure which subjects the patient to associated morbidity and costs and therefore is not desirable.

As for all systematic reviews this study is limited by the quality of evidence available. In most meta-analyses of reported complications the evidence was graded as low to very low. Furthermore, only studies written in English, German or Dutch were included in this systematic review which could be a potential limitation of this study. Complications and early re-interventions are reported in some studies, \[[@CR21], [@CR33]--[@CR35], [@CR51], [@CR54], [@CR57]\] but underreporting is very likely to occur. Most studies do not clearly report causes for implant failure, measures taken with occurrence of infection or information concerning implant migration or secondary shortening. Only few specifically report on the presence or absence of certain relevant complications such as secondary shortening, neuropathy of the supraclavicular nerve, delayed union and persistent pain. This information could be interesting to fully report in future studies and is a limitation of this review. Another limitation is that not all functional outcomes and complications were reported in a similar manner leading to heterogeneity of the various studies. To account for the expected heterogeneity, a random effects model was used. In the case of functional outcome scores for TEN and Sonoma the confidence in the estimates was high and moderate, respectively. Lastly, the follow up differed between studies ranging from 3 months to 7 years. This may have resulted in differences in reporting of complications and functional outcomes. Although most complications would likely occur within the first 3 months this could lead to underreporting this could further negatively influence the confidence in the estimates reported.

In the last years multiple meta-analysis comparing the gold standard of plate fixation and intramedullary devices (irrespective of device or plate type) for the management of midshaft clavicle fractures have been published \[[@CR82]--[@CR89]\]. These studies report similar \[[@CR82]--[@CR84], [@CR86]--[@CR88]\] or superior \[[@CR85], [@CR89]\] functional outcomes and union rates in the intramedullary fixation group. Furthermore, most report a higher rate of complications (such as infection, refracture rate) and increased surgical time when using plate fixation, making an evaluation of the devices described in the present study even more relevant \[[@CR82], [@CR83], [@CR86]--[@CR89]\].

The results of this systematic review show there is still room for improvement in treating DMCF in an intramedullary fashion. For newer designs it may be interesting to take the implant-related and implant-specific complications described in this systematic review into account in order to optimize future treatment strategies.

Conclusion {#Sec21}
==========

Although most studies were of low quality, in general, good functional results and union rates irrespective of the type of device are found in the reviewed literature. However, there are clear device-related and device-specific complications for each. The results of this systematic review and meta-analysis can help guide surgeons in choosing the appropriate operative strategy, implant and informing their patients.
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